Alpha Tau Medical Ltd. (NASDAQ:DRTSW) Sees Significant Growth in Short Interest

Alpha Tau Medical Ltd. (NASDAQ:DRTSW) was the recipient of a significant increase in short interest in August. As of August 31st, there was short interest totaling 5,312 shares, an increase of 72.3% from the August 15th total of 3,083 shares. Based on an average daily volume of 64,523 shares, the short-interest ratio is currently 0.1 days.

Alpha Tau Medical Stock Performance

NASDAQ:DRTSW traded down $0.15 during trading hours on Friday, reaching $4.22. The company’s stock had a trading volume of 5,021 shares, compared to its average volume of 62,598. The stock has a 50 day moving average price of $3.60 and a two-hundred day moving average price of $2.35. Alpha Tau Medical has a 12 month low of $0.20 and a 12 month high of $4.62.

About Alpha Tau Medical

Alpha Tau Medical Ltd. is a clinical-stage medical technology company focused on the development of alpha-emitting radiation therapy for the treatment of solid tumor cancers. The company’s proprietary Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) platform leverages the short-range, high-energy alpha particles emitted by radium-224 to penetrate tumor tissues more effectively than conventional external-beam radiation. By implanting thin, needle-like sources directly into a tumor, Alpha DaRT delivers concentrated doses of radiation to malignant cells while sparing surrounding healthy tissue.

The Alpha DaRT technology is designed to enhance local tumor control in a variety of solid tumors, including head and neck, breast, skin, and pancreatic cancers.